Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions
Fluorescence and Reflectance Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions
2 other identifiers
interventional
381
1 country
1
Brief Summary
The goal of this clinical research study is to test a new way to look for cancer and pre-cancerous tissue changes inside the mouth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 1999
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 2, 1999
CompletedFirst Submitted
Initial submission to the registry
July 24, 2007
CompletedFirst Posted
Study publicly available on registry
July 26, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 12, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 12, 2018
CompletedJanuary 19, 2018
January 1, 2018
18.5 years
July 24, 2007
January 17, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Classification of Oral Lesions
Distinguishing between normal and abnormal sites with four lesion classifications of normal, non-malignant inflammatory, dysplasia, and neoplasia.
11 Years
Study Arms (1)
Fluorescence Spectroscopy
EXPERIMENTAL1-5 lesions + several normal-looking areas inside the mouth exposed to a beam of light; exposed tissues will emit very small amounts of fluorescence (light) then will be removed.
Interventions
1-5 lesions + several normal-looking areas inside the mouth exposed to a beam of light; exposed tissues will emit very small amounts of fluorescence (light) then will be removed.
Eligibility Criteria
You may qualify if:
- \. Any person 18 years of age or older with a lesion of the oral mucosa. Persons with changes in existing lesions or those who develop new lesions can be re-evaluated, but it is not required.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ann M. Gillenwater, MD
M.D. Anderson Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 24, 2007
First Posted
July 26, 2007
Study Start
July 2, 1999
Primary Completion
January 12, 2018
Study Completion
January 12, 2018
Last Updated
January 19, 2018
Record last verified: 2018-01